GNRH1 and ovarian carcinoma: Antagonistic analogs of GnRH and GnRH-II directly induce endometrial and ovarian cancer cell apoptosis through a dose-dependent loss of mitochondrial membrane potential and subsequent activation of caspase-3 (12).